Thierry Bordet
CSO/COO PulseSight Therapeutics
False
Thierry Bordet
CSO/COO PulseSight Therapeutics
October 29, 2025
Could restoring iron homeostasis in the eye through transferrin regulation offer a new therapeutic avenue for dry AMD?
5 min read
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False
False
False
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: